Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yeonjoo Hwang

4PUBLICATIONS

21CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Dec 11, 2023

The therapeutically actionable long non-coding RNA '<i>T-RECS</i>' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.

Valentin Feichtenschlager, Linan Chen, Yixuan James Zheng

|Feb 09, 2023

A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumors.

Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang

|Jan 28, 2022

Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1.

James E Melnyk, Veronica Steri, Hao G Nguyen

|May 30, 2019

KRAS<sup>G12C</sup> inhibition produces a driver-limited state revealing collateral dependencies.

Kevin Lou, Veronica Steri, Alex Y Ge

Pageof 1

Frequent Collaborators

3 joint publications

Kevan Shokat

2 joint publications

John D Gordan

1 joint publications

Kevin Lou

1 joint publications

Arielle R Shkedi

1 joint publications

Dominique C Mitchell

1 joint publications

Danielle L Swaney

1 joint publications

Byron Hann

1 joint publications

Luke A Gilbert

1 joint publications

James E Melnyk

1 joint publications

Felix Y Feng

Frequent Collaborators

3 joint publications

Kevan Shokat

2 joint publications

John D Gordan

1 joint publications

Kevin Lou

1 joint publications

Arielle R Shkedi

Top Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on : Mar 08, 2022

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models

Published on : Dec 09, 2016

See more related videos

Top Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on : Mar 08, 2022

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models

Published on : Dec 09, 2016

See more related videos